BioAegis Therapeutics and EastHORN Expand Phase 2 COVID-19 Clinical Trial within Spain and into Romania
BioAegis’ Phase 2 clinical trial of recombinant human plasma...
BioAegis’ Phase 2 clinical trial of recombinant human plasma...
Our priorities at this challenging time are the well-being o...
EastHORN will be present at OCT West Coast in San Francisco,...
EastHORN is pleased to announce its participation at this ye...